CorMedix Inc. (CRMD)
NASDAQ · Healthcare
CorMedix Inc. Shareholder Equity 2012–2025
CorMedix Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- CorMedix Inc. shareholder equity as of December 31, 2025: 405.3M, a 378.76% increase year-over-year.
- CorMedix Inc. shareholder equity for 2025 were 405.3M, a 378.76% increase from 2024.
- CorMedix Inc. shareholder equity for 2024 were 84.7M, a 53.75% increase from 2022.
- CorMedix Inc. shareholder equity for 2022 were 55.1M, a 12.32% decrease from 2021.
- CorMedix Inc. shareholder equity for 2021 were 62.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| CorMedix Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $405 |
| 2024 | $85 |
| 2022 | $55 |
| 2021 | $63 |
| 2020 | $44 |
| 2019 | $24 |
| 2018 | $5 |
| 2017 | $7 |
| 2016 | $18 |
| 2015 | $34 |
| 2014 | $4 |
| 2013 | $-4 |
| 2012 | $-0 |
CorMedix Inc. Shareholder Equity — FAQ
CorMedix Inc. (CRMD) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRMD's shareholder equity history?
The chart and table above show CorMedix Inc.'s shareholder equity by year and by quarter, including the growth rate.